← FDA DRUG APPROVALS

FDA ANDA · ANDA088488

HYDROXYZINE PAMOATE

Sponsor: BARR LABS

APPLICATION
ANDA088488
TYPE
ANDA
ORIGINAL APPROVAL
1984-06-15
LATEST ACTION
2021-02-16
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

HYDROXYZINE PAMOATEPrescription
HYDROXYZINE PAMOATE EQ 100MG HYDROCHLORIDE · CAPSULE · ORAL

Approval history

2021-02-16Labeling · Supplement 52 · standardAP
2021-02-16Labeling · Supplement 51 · standardAP
2015-01-24Labeling · Supplement 48 · standardAP
2011-07-27Manufacturing (CMC) · Supplement 44AP
2008-05-28Labeling · Supplement 43AP
2003-01-03Manufacturing (CMC) · Supplement 33AP
2002-04-29Manufacturing (CMC) · Supplement 32AP
2001-11-09Labeling · Supplement 31AP
2001-11-09Labeling · Supplement 30AP
2000-02-03Manufacturing (CMC) · Supplement 29AP
1999-12-21Manufacturing (CMC) · Supplement 28AP
1999-06-11Manufacturing (CMC) · Supplement 27AP
1999-05-20Manufacturing (CMC) · Supplement 26AP
1998-12-01Manufacturing (CMC) · Supplement 24AP
1998-11-16Manufacturing (CMC) · Supplement 25AP
1998-11-16Manufacturing (CMC) · Supplement 23AP
1998-11-16Manufacturing (CMC) · Supplement 22AP
1996-09-20Labeling · Supplement 21AP
1996-04-10Labeling · Supplement 20AP
1995-01-12Manufacturing (CMC) · Supplement 13AP
1995-01-12Labeling · Supplement 14AP
1994-12-23Manufacturing (CMC) · Supplement 19AP
1994-10-11Manufacturing (CMC) · Supplement 18AP
1992-04-03Manufacturing (CMC) · Supplement 17AP
1992-04-03Manufacturing (CMC) · Supplement 15AP
1991-05-09Labeling · Supplement 12AP
1990-01-04Labeling · Supplement 11AP
1989-09-12Labeling · Supplement 10AP
1987-11-18Manufacturing (CMC) · Supplement 7AP
1987-11-18Manufacturing (CMC) · Supplement 8AP
1987-03-31Manufacturing (CMC) · Supplement 6AP
1984-09-25Manufacturing (CMC) · Supplement 2AP
1984-06-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →